The latest in substance use disorders and pain management education for providers

January 2022

EDUCATION

Understanding the Opioid Epidemic

Prescribers' Next Steps in the Treatment of Opioid Use Disorder

Tuesday, January 11 | 12:00 - 1:00 pm

Understanding the Opioid Epidemic

Providers' Role in the Treatment of Opioid Use Disorder

Thursday, January 20 | 12:00 - 1:00 pm

MACS TeleECHO Clinics

Monthly virtual case-based learning and didactic presentations linking expert specialist teams with prescribers and their practices.

Opioid Treatment Program Clinic

Systemic Racism

Wednesday, January 12

12:30 - 1:45 pm

Primary Care Clinic

Patient Retention and Care Continuity

Wednesday, January 19

12:30 - 1:45 pm

Maternal Health Clinic

Motivational Interviewing

Monday, February 14

12:00 - 1:00 pm

8-Hour Waiver Training Buprenorphine for the Treatment of Opioid Use Disorder

Tuesday, February 8 | 8:00 am - 5:15 pm

Starting Buprenorphine in the Fentanyl Era:

Is low-dose initiation (“microdosing”) the solution?

Wednesday, February 23 | 12:00 - 1:00 pm

NEWS

team of medical professionals standing together

A Call to Action: Maryland Prescribers’ Role in Addressing the Overdose Crisis

Aliya Jones, MD, the Deputy Secretary of the Maryland Department of Health's Behavioral Health Administration, calls on all Maryland prescribers to help address the overdose crisis.

Making Addiction Treatment More Realistic And Pragmatic: The Perfect Should Not Be The Enemy Of The Good

The magnitude of the drug overdose crisis requires expanding treatment and recovery approaches beyond abstinence-only models and understanding that treatment and recovery methods look different for each person.

Associations between discrimination and substance use among college students in the United States from 2015 to 2019

"Discrimination has been associated with adverse health behaviors and outcomes, including substance use. Higher rates of substance use are reported among some marginalized groups, such as lesbian, gay, and bisexual populations, and have been partially attributed to discrimination."

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program

This study found the number of waivered providers and the overall buprenorphine prescribing capacity increased substantially after policies expanded buprenorphine waivers to NP/PAs.

Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020

Urgent action is needed to slow and reverse rapid increases in drug overdose deaths involving IMFs and other drugs. This report examines data from 2019-2020 to better inform the increase in overdose deaths.